1. Chemokine receptor 5 antagonist, maraviroc, does not affect the progression of aortic stenosis in hypercholesterolemic mice. (August 2021) Authors: Weisell, J.; Ylä-Herttuala, E.; Ruotsalainen, A.-K.; Laakso, H.; Liimatainen, T.; Rysä, J. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗